Recurrent atherosclerotic cardiovascular disease

1. Trimethylamine n-oxide is associated with recurrent atherosclerotic cardiovascular disease in humans (HR 1.25 (95% CI 1.01–1.56); P-trend=0.009).

   “Among individuals with prior ASCVD, TMAO associated with higher risk of recurrent ASCVD”

   HumansPrior atherosclerotic cardiovascular disease; no significant modification by eGFRplasman = 1,449

   Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults

   Journal of the American Heart Association·16 Aug 2021

More on Trimethylamine n-oxide